Marketing-authorisation holder · United States
Uswm Ct, LLC
2 medicines in 1 country, as authorisation holder.
Medicines
Every medicine in the registers under its name, current ones first.
2 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| tecelra1.62 x 10^9 to 10 x 10^9 CELL/ML · Suspension | Afamitresgene autoleucel | United States | Marketed | 2026 |
| tecelra2.68 x 10^9 to 10 x 10^9 CELL/ML · Suspension | Afamitresgene autoleucel | United States | Marketed | 2024 |
Countries
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| United States | 2 | 2 | 0 | CompaniesAll medicines |
Top substances
The active substances in most of its medicines.
Names in the registers
How the registers spell it, normalised: legal forms, accents and capitals removed.



